English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Accepted: 16 Jul, 2017 Abstract Background and Objectives: Telomerase is an enzyme, which is overexpressed in 80-90% of cancers. Simultaneous activities of telomerase and NF-κB are required for progression of many cancers. In recent years, researchers have found out a close relationship between telomerase and the transcription factor NF-κB. Increased expression of telomerase is associated with significant increases in the expression level of NF-κB and endogenous genes, such as IL-6 and TNF-α. In recent years, several methods have been proposed to inhibit telomerase in cancer cells. Therefore, If it is possible to inhibit telomerase activity and consequently reduce the expression of inflammatory cytokines, the NF-κB signaling pathway, and the expression of target genes in the multiple myeloma disease. In this study, the effect of MST-312 (a derivative of green tea) with telomerase inhibition activity, was investigated on the treated U266 cell line and the expression of inflammatory cytokines.

The Effect of Telomerase Inhibition on the Expression of Inflammatory Cytokines Affecting the Pathogenesis of Multiple Myeloma Cell Line U266